In Stent ELUTES Study (ELUTES II)
Coronary Artery Disease

About this trial
This is an interventional treatment trial for Coronary Artery Disease focused on measuring coronary artery, stent, drug eluting, patency, restenosis
Eligibility Criteria
Inclusion Criteria: Patient has given informed consent Patient has target lesion in native coronary artery or coronary bypass graft Patient has in-stent restenosis >60% Patient has reference artery diameter 2.7-3.5 Patient agrees to return for clinical assessment at 1, 6, 9, 12 and 24 months and for a treadmill test at 9 months and an angiogram at 9 months and 24 months. Exclusion Criteria: Patient is less than 18 years of age Patient is pregnant or breast feeding Patient has history of bleeding diathesis or coagulopathy or will refuse blood transfusions. Patient is simultaneously participating in another investigative interventional cardiovascular drug or device study. Patient has known hypersensitivity or contraindication to aspirin or stainless steel or a sensitivity to contrast agent.
Sites / Locations
- Contact Sponsor